- Home
- FULTP vs CERT Comparison
FULTP vs CERT Comparison
Compare FULTP & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FULTP
Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Current Price
Company Overview
Basic Information| Metric | FULTP | CERT |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | 3400 | 1546 |
| Industry | Major Banks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 1.4B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | FULTP | CERT |
|---|---|---|
| Price | $19.22 | $8.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $13.88 |
| AVG Volume (30 Days) | N/A | ★ 2.0M |
| Earning Date | N/A | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $415,551,000.00 |
| Revenue This Year | N/A | $10.82 |
| Revenue Next Year | N/A | $6.77 |
| P/E Ratio | ★ N/A | $126.84 |
| Revenue Growth | N/A | ★ 11.47 |
| 52 Week Low | N/A | $8.03 |
| 52 Week High | N/A | $15.69 |
Technical Indicators
Market Signals| Indicator | FULTP | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 45.98 | 40.96 |
| Support Level | $19.00 | $8.95 |
| Resistance Level | $19.43 | $9.42 |
| Average True Range (ATR) | 0.21 | 0.39 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 48.28 | 25.99 |
Price Performance
Historical ComparisonAbout FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.